Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy.

ASAKURA M; KITAKAZE M; TAKASHIMA S; YOSHINO K; ISHIGURO H; TAKEDA H; BEPPU S; TADA M; HIGASHIYAMA S

Art

J-GLOBAL ID：200902199403159789 Reference number：02A0210001

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy.

心肥大はHB-EGFのADAM12プロセシングのきっ抗作用によって阻害される新治療薬としてのメタロプロテイナーゼ阻害剤

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=02A0210001&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=02A0210001&from=J-GLOBAL&jstjournalNo=W0636A") }}

Author (9)： , , , , , , , ,
Material：
Volume： 8 Issue： 1 Page： 35-40 Publication year： Jan. 01, 2002
JST Material Number： W0636A ISSN： 1078-8956 Document type： Article
Article type：短報 Country of issue： United States (USA) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=02A0210001&from=J-GLOBAL&jstjournalNo=W0636A") }}

Cardiovascular system diseases , Basic research of enzyme preparations and enzyme inhibitor preparations , Gene expression

, , , , , , , ,

Return to Previous Page